Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-02-15

Clinical Trial Update: The Efficacy of Stellate Ganglion Block as Post-traumatic Stress Disorder (PTSD) Therapy: A Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 pilot study is evaluating stellate ganglion block as a therapy for post-traumatic stress disorder. The current status of the trial is not reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Southern California Institute for Research and Education | Conditions: Stress Disorders, Post-Traumatic | Phase 2 | Status: UNKNOWN